GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OTCPK:CLPBF) » Definitions » Margin of Safety % (DCF Earnings Based)

CLPBF (Coloplast AS) Margin of Safety % (DCF Earnings Based) : -154.21% (As of Dec. 13, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Coloplast AS Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2024-12-13), Coloplast AS's Predictability Rank is 3.5-Stars. Coloplast AS's intrinsic value calculated from the Discounted Earnings model is $44.27 and current share price is $112.54. Consequently,

Coloplast AS's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is -154.21%.


Competitive Comparison of Coloplast AS's Margin of Safety % (DCF Earnings Based)

For the Medical Instruments & Supplies subindustry, Coloplast AS's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Margin of Safety % (DCF Earnings Based) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Margin of Safety % (DCF Earnings Based) falls into.



Coloplast AS Margin of Safety % (DCF Earnings Based) Calculation

Coloplast AS's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(44.27-112.54)/44.27
=-154.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.


Coloplast AS Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Industry
Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

From GuruFocus

Q1 2021 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2020 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Q2 2021 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S Virtual Deep-Dive Sessions Transcript

By GuruFocus Research 02-13-2024